Journal•ISSN: 1549-4810
The Journal of pharmacy technology
SAGE Publishing
About: The Journal of pharmacy technology is an academic journal published by SAGE Publishing. The journal publishes majorly in the area(s): Pharmacy & Medicine. It has an ISSN identifier of 1549-4810. Over the lifetime, 1392 publications have been published receiving 4852 citations. The journal is also known as: JPT.
Topics: Pharmacy, Medicine, Pharmacist, Clinical pharmacy, Internal medicine
Papers published on a yearly basis
Papers
More filters
TL;DR: Reading preparing a health care workforce for the 21st century the challenge of chronic conditions is also a way as one of the collective books that gives many advantages.
Abstract: No wonder you activities are, reading will be always needed. It is not only to fulfil the duties that you need to finish in deadline time. Reading will encourage your mind and thoughts. Of course, reading will greatly develop your experiences about everything. Reading preparing a health care workforce for the 21st century the challenge of chronic conditions is also a way as one of the collective books that gives many advantages. The advantages are not only for you, but for the other peoples with those meaningful benefits.
188 citations
177 citations
166 citations
TL;DR: Combined analysis of all studies examined in this article yields a success rate of 54% for valproate in the treatment of acute mania, which recommends valproates as suitable alternative treatment for acutely manic patients who do not respond to lithium or cannot tolerate its adverse effects.
Abstract: Objective:To determine whether valproate is effective for the acute treatment of mania.Data Sources:Pertinent literature was identified through a MEDLINE search.Study Selection:Blinded, controlled, or other high-quality trials with adequate sample size evaluating valproate in the treatment of acute mania were selected.Data Extraction:Study selection for the review was based on the quality of the trial and the clinical endpoint of control of acute manic symptoms using valproate.Data Synthesis:Acute manic episodes in bipolar disease are disabling and dangerous. A minority of acutely manic patients either do not respond to treatment with lithium or cannot tolerate its adverse effects. Valproate is a viable but slightly less effective alternative in the patients who cannot use lithium.Conclusions:Combined analysis of all studies examined in this article yields a success rate of 54% for valproate in the treatment of acute mania. This efficacy rate recommends valproate as suitable alternative treatment for acut...
108 citations
TL;DR: Ambrisentan appears to be a promising treatment option for patients affected by PAH, given its improved drug–drug interaction and hepatotoxicity profile compared with other endothelin antagonists.
Abstract: Objective:To review the pharmacology, pharmacokinetics, efficacy, and safety of ambrisentan, a selective endothelin type A (ETA) receptor antagonist, for the treatment of pulmonary arterial hyperte...
68 citations